Volume 11, Issue 6 (November & December - In Press 2020)                   BCN 2020, 11(6): 9-9 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Esmaeili S, Shojaei S F, Bahadori M, Mojtahed M, Mehrpour M. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cardiac Myxoma; A Case Report. BCN. 2020; 11 (6) :9-9
URL: http://bcn.iums.ac.ir/article-1-1494-en.html
1- MD-MPH, Clinician Scientist Trainee. Firoozgar Hospital, Department of neurology, Cellular and Molecular Research Center, Student Research Committee, Iran University of Medical Sciences, Tehran-Iran.
2- MSc, Clinical Psychologist. Firoozgar Clinical Research and Development Center (FCRDC), Iran University of Medical Sciences, Tehran, Iran.
3- MD. Department of neurology, Iran University of Medical Sciences, Tehran-Iran.
4- MD, Iran University of Medical Sciences, Tehran-Iran.
5- MD-MPH, Firoozgar Hospital,Department of neurology, Iran University of Medical Sciences, Tehran-Iran.
Abstract:  
Myxoma may cause systemic embolization and frequently presents as ischemic stroke. There has been debates whether it is safe to use recombinant tissue plasminogen activator (rt-PA) in patients with cardiac myxoma who are presented with ischemic stroke at emergency department. we describe a young case of atrial myxoma with initial presentation of acute cerebral infarction symptoms who was treated with intravenous rt-PA with no complications
 
 
     
Type of Study: News and Reports | Subject: Clinical Neuroscience
Received: 2019/05/8 | Accepted: 2020/02/10 | Published: 2018/03/15

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb